Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Simvastatin
Crescent Pharma Ltd
C10AA01
Simvastatin
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02120000; GTIN: 5017123299230
PATIENT INFORMATION LEAFLET SIMVASTATIN 10 MG TABLETS PLEASE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. KEEP THE LEAFLET; YOU MAY NEED TO READ IT AGAIN. IF YOU HAVE ANY QUESTIONS OR ARE NOT SURE ABOUT ANYTHING, ASK YOUR DOCTOR OR PHARMACIST. THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. DO NOT PASS IT ON TO OTHERS. IT MAY HARM THEM, EVEN IF THEIR SYMPTOMS ARE THE SAME AS YOURS. IF YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR, PHARMACIST OR NURSE. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS NOT LISTED IN THIS LEAFLET. SEE SECTION 4. IN THIS LEAFLET: 1. What Simvastatin Tablets are and what they are used for 2. Before you take Simvastatin Tablets 3. How to take Simvastatin Tablets 4. Possible side effects 5. How to store Simvastatin Tablets 6. Further information 1. WHAT SIMVASTATIN TABLETS ARE AND WHAT THEY ARE USED FOR This medicine contains simvastatin which belongs to a group of drugs known as HMG-CoA reductase inhibitors. These are used to reduce the amount of cholesterol and fatty substances called triglycerides in your blood. Cholesterol is vital to the normal functioning of the body, but if levels of cholesterol in the bloodstream get too high it can be deposited on the walls of the arteries, where it builds up eventually leading to the blocking of the blood vessel. Only a small amount of cholesterol comes from our diet. Nearly all of the cholesterol in our bodies is made by our own livers and is produced mostly at night. If you have had a blood test which shows that you have too much fat (including cholesterol) in your blood, this medicine should lower these levels which will reduce the risk of developing heart disease. If you have coronary heart disease, simvastatin will lessen the risk of heart attack or of needing heart surgery. 2. BEFORE YOU TAKE SIMVASTATIN TABLETS DO NOT TAKE THESE TABLETS IF: • you are allergic to simvastatin or to any of the other ingredients (see section 6) • you are pregnant or breastfeeding (see “Pregnancy and breast feeding” section below) • y Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Simvastatin 10 mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 10 mg of the active ingredient simvastatin. Excipient with known effect: Lactose monohydrate (tablet core and tablet coat) 72.03 mg per film-coated tablet For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. Simvastatin 10 mg film-coated tablets are presented as “dark peach to pink” coloured, oval shaped, film-coated tablets with “G” on one side and “SM” scoreline “10” on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Hypercholesterolaemia Treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate. Cardiovascular prevention Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The dosage range is 5-80 mg/day of simvastatin given orally as a single dose in the evening. Adjustments of dosage, if required, should be made at intervals of not less than 4 weeks, to a maximum of 80 mg/day given as a single dose in the evening. The 80-mg dose is only recommended in patients with severe hypercholesterolaemia and at high risk for cardiovascular complications, who have not achieved their treatment goals on lower doses and when the benefits are expected to outweigh Read the complete document